Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 0 | 5,168 | 4,580 |
| Cost of Goods | N/A | N/A | N/A | 2,938 | 1,344 |
| Gross Profit | N/A | N/A | N/A | 2,230 | 3,236 |
| Operating Expenses | 2,008 | 2,019 | 1,015 | 4,395 | 3,896 |
| Operating Income | -2,008 | -2,019 | -1,015 | -1,227 | -316 |
| Other Income | -13 | -14 | -5 | -69 | -16 |
| Pre-tax Income | -2,020 | -2,033 | -1,019 | -1,296 | -332 |
| Income Tax | N/A | N/A | N/A | -3 | 19 |
| Net Income Continuous | -2,020 | -2,033 | -1,019 | -1,293 | -351 |
| Net Income | $-2,020 | $-2,033 | $-1,019 | $-1,293 | $-351 |
| EPS Basic Total Ops | -32.98 | -35.98 | -17.99 | -275.86 | -71.96 |
| EPS Basic Continuous Ops | -34.36 | -34.68 | -17.46 | -269.45 | -73.24 |
| EPS Diluted Total Ops | -32.98 | -35.98 | -17.99 | -275.86 | -71.96 |
| EPS Diluted Continuous Ops | -34.36 | -34.68 | -17.46 | -269.45 | -73.24 |
| EBITDA(a) | $-1,982 | $-1,995 | $-992 | $33 | $547 |